特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959781

乾癬治療薬の世界市場:新型コロナウイルス感染症 (COVID-19) の影響と回復過程 (2020~30年)

Psoriasis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
乾癬治療薬の世界市場:新型コロナウイルス感染症 (COVID-19) の影響と回復過程 (2020~30年)
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の乾癬治療薬の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (2015~2019年、2023年、2025年、2030年)、薬剤クラス別・流通チャネル別・薬剤の種類別・投与経路別・症状別・地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 乾癬治療薬市場の特徴

第3章 乾癬治療薬市場:市場規模・成長率

  • 市場規模 (金額ベース、2015~2019年)
  • 市場規模 (金額ベース、2019~2023年、2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第4章 乾癬治療薬市場:分野別の分析

  • 薬剤クラス別の市場規模 (金額ベース、実績値・予測値)
    • インターロイキン阻害剤
    • コルチコステロイド
    • 抗炎症薬
    • 腫瘍壊死因子 (TNF) 阻害剤
  • 流通チャネル別の市場規模 (金額ベース、実績値・予測値)
    • 病院
    • 小売薬局
    • eコマース
  • 薬剤の種類別の市場規模 (金額ベース、実績値・予測値)
    • 小分子
    • 生物製剤
  • 投与経路別の市場規模 (金額ベース、実績値・予測値)
    • 経口投与
    • 局所投与
    • 注射
  • 症状別の市場規模 (金額ベース、実績値・予測値)
    • 尋常性乾癬
    • 爪乾癬
    • 滴状乾癬
    • 膿疱性乾癬
    • 紅皮性症乾癬

第5章 乾癬治療薬市場:地域別・国別分析

  • 地域別の市場規模 (金額ベース、実績値・予測値)
  • 国別の市場規模 (金額ベース、実績値・予測値)

第6章 アジア太平洋の乾癬治療薬市場

  • 市場概要
  • 薬剤クラス別の市場規模 (金額ベース、実績値・予測値)
  • 流通チャネル別の市場規模 (金額ベース、実績値・予測値)

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧の乾癬治療薬市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧の乾癬治療薬市場

第18章 ロシア市場

第19章 北米の乾癬治療薬市場

第20章 米国市場

第21章 南米の乾癬治療薬市場

第22章 ブラジル市場

第23章 中東の乾癬治療薬市場

第24章 アフリカの乾癬治療薬市場

第25章 乾癬治療薬市場:競争環境と企業プロファイル

  • 競争環境
  • 企業プロファイル
    • AbbVie Inc.
    • Pfizer Inc.
    • Novartis
    • Eli Lilly and Company.
    • Celgene Corporation

第26章 乾癬治療薬市場における主要な企業合併・買収 (M&A)

第27章 乾癬治療薬市場の動向と戦略

第28章 乾癬治療薬市場:将来展望と潜在力の分析

第29章 付録

目次

Psoriasis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global psoriasis drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor

2) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce

3) By Drug Types: Small molecules; Biologics

4) By Route Of Administration: Oral; Tropical; Injectable

5) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis

Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis; Eli Lilly and Company.; Celgene Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Psoriasis Drugs Market Characteristics

3. Psoriasis Drugs Market Size And Growth

  • 3.1. Global Psoriasis Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Psoriasis Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Psoriasis Drugs Market Segmentation

  • 4.1. Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Interleukin Inhibitors
    • Corticosteroids
    • Anti-Inflammatory
    • Tumor Necrosis Factor Inhibitor
  • 4.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospitals
    • Retail Pharmacies
    • E-commerce
  • 4.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Small Molecules
    • Biologics
  • 4.4. Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Oral
    • Tropical
    • Injectable
  • 4.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Plaque Psoriasis
    • Nail Psoriasis
    • Guttate Psoriasis
    • Pustular Psoriasis
    • Erythrodermic Psoriasis

5. Psoriasis Drugs Market Regional And Country Analysis

  • 5.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Psoriasis Drugs Market

  • 6.1. Asia-Pacific Psoriasis Drugs Market Overview
  • 6.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Psoriasis Drugs Market

  • 7.1. China Psoriasis Drugs Market Overview
  • 7.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Psoriasis Drugs Market

  • 8.1. India Psoriasis Drugs Market Overview
  • 8.2. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Psoriasis Drugs Market

  • 9.1. Japan Psoriasis Drugs Market Overview
  • 9.2. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Psoriasis Drugs Market

  • 10.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Psoriasis Drugs Market

  • 11.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Psoriasis Drugs Market

  • 12.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Psoriasis Drugs Market

  • 13.1. Western Europe Psoriasis Drugs Market Overview
  • 13.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Psoriasis Drugs Market

  • 14.1. UK Psoriasis Drugs Market Overview
  • 14.2. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Psoriasis Drugs Market

  • 15.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Psoriasis Drugs Market

  • 16.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Psoriasis Drugs Market

  • 17.1. Eastern Europe Psoriasis Drugs Market Overview
  • 17.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Psoriasis Drugs Market

  • 18.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Psoriasis Drugs Market

  • 19.1. North America Psoriasis Drugs Market Overview
  • 19.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Psoriasis Drugs Market

  • 20.1. USA Psoriasis Drugs Market Overview
  • 20.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Psoriasis Drugs Market

  • 21.1. South America Psoriasis Drugs Market Overview
  • 21.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Psoriasis Drugs Market

  • 22.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Psoriasis Drugs Market

  • 23.1. Middle East Psoriasis Drugs Market Overview
  • 23.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Psoriasis Drugs Market

  • 24.1. Africa Psoriasis Drugs Market Overview
  • 24.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Psoriasis Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Psoriasis Drugs Market Competitive Landscape
  • 25.2. Psoriasis Drugs Market Company Profiles
    • 25.2.1. AbbVie Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Pfizer Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Eli Lilly and Company.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Celgene Corporation
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Psoriasis Drugs Market

27. Psoriasis Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Psoriasis Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.